Table 3. Culture results, sorting based on NF Types and isolated pathogens from patients with upper extremity NF.
| Total n=255 (100%) | |
| Patients with specific organisms isolated (positive cultures), n (%) | 232 (91,0%) |
| Type 1 | 60 (25,9%) |
| Type 2 | 126 (54,3%) |
| Type 3 | 43 (18,5%) |
| Type 4 | 3 (1,3%) |
| Group A beta-haemolytic Streptococcus | 98 (42,2%) |
| Other Streptococcus species | 48 (20,7%) |
| Staphylococcus aureus Of which Methicillin-resistant Staphylococcus aureus (MRSA) | 45 (19,4%) 21 (9,1%) |
| Other Staphylococcus species | 16 (6,9%) |
| Bacteroides spp. | 10 (4,3%) |
| Enterococci spp. | 11 (4,7%) |
| Escherichia coli | 3 (1,3%) |
| Clostridium spp. | 10 (4,3%) |
| Vibrio spp. | 17 (7,3%) |
| Klebsiella spp. | 7 (3,0%) |
| Pseudomonas spp. | 4 (1,7%) |
| Aeromonas spp. | 3 (1,3%) |
| Other | 38 (16,4%) |
| Patients without specific organisms isolated (negative cultures) | 23 (9,0%) |